|
|
|
|
|
Legal status
Patent not validated
| (51) | INT.CL. | A61K 31/7072 | |
| A61K 31/337 | |||
| A61K 31/513 | |||
| A61P 1/00 | |||
| A61P 11/00 | |||
| A61P 15/00 | |||
| A61P 35/00 | |||
| A61P 43/00 |
| (11) | Number of the document | 3127545 |
| (13) | Kind of document | T |
| (96) | European patent application number | 15774351.9 |
| Date of filing the European patent application | 2015-04-03 | |
| (97) | Date of publication of the European application | 2017-02-08 |
| (45) | Date of publication and mention of the grant of the patent | 2020-06-03 |
| (46) | Date of publication of the claims translation |
| (86) | Number | PCT/JP2015/060645 |
| Date | 2015-04-03 |
| (87) | Number | WO 2015/152409 |
| Date | 2015-10-08 |
| (30) | Number | Date | Country code |
| 2014078243 | 2014-04-04 | JP |
| (72) |
OKABE, Hiroyuki, JP
|
| (73) |
Taiho Pharmaceutical Co., Ltd.,
1-27, Kanda Nishiki-cho, Chiyoda-ku Tokyo 101-8444,
JP
|
| (54) | ANTI-TUMOR DRUG CONTAINING TAXANE COMPOUND, AND ANTI-TUMOR EFFECT ENHANCER |
| ANTI-TUMOR DRUG CONTAINING TAXANE COMPOUND, AND ANTI-TUMOR EFFECT ENHANCER |